117 related articles for article (PubMed ID: 18362937)
1. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
[TBL] [Abstract][Full Text] [Related]
2. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
3. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
4. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
5. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
[TBL] [Abstract][Full Text] [Related]
6. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
[TBL] [Abstract][Full Text] [Related]
7. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma.
Li C; Zhao H; Hu Z; Liu Z; Wang LE; Gershenwald JE; Prieto VG; Lee JE; Duvic M; Grimm EA; Wei Q
Hum Mutat; 2008 Dec; 29(12):1443-51. PubMed ID: 18563783
[TBL] [Abstract][Full Text] [Related]
10. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
11. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
[TBL] [Abstract][Full Text] [Related]
12. Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer.
Wu Z; Li Y; Li S; Zhu L; Li G; Yu Z; Zhao X; Ge J; Cui B; Dong X; Tian S; Hu F; Zhao Y
Med Oncol; 2013; 30(3):565. PubMed ID: 23715747
[TBL] [Abstract][Full Text] [Related]
13. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
14. Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study.
Pardini B; Verderio P; Pizzamiglio S; Nici C; Maiorana MV; Naccarati A; Vodickova L; Vymetalkova V; Veneroni S; Daidone MG; Ravagnani F; Bianchi T; Bujanda L; Carracedo A; Castells A; Ruiz-Ponte C; Morreau H; Howarth K; Jones A; Castellví-Bel S; Li L; Tomlinson I; Van Wezel T; Vodicka P; Radice P; Peterlongo P;
PLoS One; 2014; 9(1):e85538. PubMed ID: 24465592
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous Ins/Del genotype of the CASP8 rs3834129 polymorphism significantly decreases the risk of coal workers' pneumoconiosis in a Chinese Han population: a case-control study.
Hou ZF; Wang H; Ji SQ; Kang DM; Zhao H; Guo Y; Ma JF; Wang JZ; Ma X; Gao Y
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7726-7733. PubMed ID: 34982434
[TBL] [Abstract][Full Text] [Related]
19. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma.
Zhu J; Qin C; Wang M; Yan F; Ju X; Meng X; Ding Q; Li P; Yang J; Cao Q; Zhang Z; Yin C
Mol Carcinog; 2010 Sep; 49(9):810-7. PubMed ID: 20572163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]